Journal article
929b Larazotide Acetate, a First In-Class, Novel Tight Junction Regulator, Meets Primary Endpoint and Significantly Reduces Signs and Symptoms of Celiac Disease in Patients on a Gluten-Free Diet: Results of a Multicenter, Randomized, Placebo Controlled Trial
Authors
Wang C; Rasmussen H; Perrow W; Kelly CP; Leffler D; Green P; Fedorak RN; DiMarino AJ; Bercik P; Murray JA
Journal
Gastroenterology, Vol. 146, No. 5, pp. s–159
Publisher
Elsevier
Publication Date
May 1, 2014
DOI
10.1016/s0016-5085(14)60566-7
ISSN
0016-5085